These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39039982)

  • 1. Hyaluronic Acid Receptor-Mediated Nanomedicines and Targeted Therapy.
    Ouyang Q; Zhao Y; Xu K; He Y; Qin M
    Small Methods; 2024 Oct; 8(10):e2400513. PubMed ID: 39039982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment.
    Rao NV; Yoon HY; Han HS; Ko H; Son S; Lee M; Lee H; Jo DG; Kang YM; Park JH
    Expert Opin Drug Deliv; 2016; 13(2):239-52. PubMed ID: 26653872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy.
    Gao M; Deng H; Zhang W
    Curr Top Med Chem; 2021; 21(2):126-139. PubMed ID: 32962617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review.
    Zhang R; Zhao X; Jia A; Wang C; Jiang H
    Int J Biol Macromol; 2023 Sep; 249():125993. PubMed ID: 37506794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Hyaluronic Acid-Based Drug Delivery Systems.
    Jiao Y; Pang X; Zhai G
    Curr Drug Targets; 2016; 17(6):720-30. PubMed ID: 26028046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles.
    Cai J; Fu J; Li R; Zhang F; Ling G; Zhang P
    Carbohydr Polym; 2019 Mar; 208():356-364. PubMed ID: 30658811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid in ocular drug delivery.
    Zhang X; Wei D; Xu Y; Zhu Q
    Carbohydr Polym; 2021 Jul; 264():118006. PubMed ID: 33910737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilized, ROS-sensitive β-cyclodextrin-grafted hyaluronic supramolecular nanocontainers for CD44-targeted anticancer drug delivery.
    Zhang X; Wang P; Wang X; Xu Y; Cheng T; Zhang C; Ding J; Shi Y; Ma W; Yu CY; Wei H
    Colloids Surf B Biointerfaces; 2024 Oct; 242():114081. PubMed ID: 39003850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-Prodrug-Based Hyaluronic Acid Nanoplatform Provides Cascade-Boosted Drug Delivery for Oxidative Stress-Enhanced Chemotherapy.
    Zhang J; Deng M; Xu C; Li D; Yan X; Gu Y; Zhong M; Gao H; Liu Y; Zhang J; Qu X; Zhang J
    ACS Appl Mater Interfaces; 2024 Sep; 16(38):50459-50473. PubMed ID: 39258403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
    Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
    Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical modification of hyaluronic acid as a strategy for the development of advanced drug delivery systems.
    Bokatyi AN; Dubashynskaya NV; Skorik YA
    Carbohydr Polym; 2024 Aug; 337():122145. PubMed ID: 38710553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system.
    Huang G; Huang H
    J Control Release; 2018 May; 278():122-126. PubMed ID: 29649528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
    Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
    Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
    Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells.
    Tran TH; Choi JY; Ramasamy T; Truong DH; Nguyen CN; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2014 Dec; 114():407-415. PubMed ID: 25263908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.
    Lee S; Lee SA; Shinn J; Lee Y
    Int J Nanomedicine; 2024; 19():4893-4906. PubMed ID: 38828202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.
    Choi KY; Saravanakumar G; Park JH; Park K
    Colloids Surf B Biointerfaces; 2012 Nov; 99():82-94. PubMed ID: 22079699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy.
    Wickens JM; Alsaab HO; Kesharwani P; Bhise K; Amin MCIM; Tekade RK; Gupta U; Iyer AK
    Drug Discov Today; 2017 Apr; 22(4):665-680. PubMed ID: 28017836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
    Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
    Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging the gap in rheumatoid arthritis treatment with hyaluronic acid-based drug delivery approaches.
    Priya S; Daryani J; Desai VM; Singhvi G
    Int J Biol Macromol; 2024 Jun; 271(Pt 1):132586. PubMed ID: 38795889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.